Time to review the role of surrogate endpoints in health policy: state of the art and the way forward

Ciani, O., Buyse, M., Drummond, M., Rasi, G., Saad, E. D. and Taylor, R. S. (2017) Time to review the role of surrogate endpoints in health policy: state of the art and the way forward. Value in Health, 20(3), pp. 487-495. (doi: 10.1016/j.jval.2016.10.011) (PMID:28292495)

[img]
Preview
Text
201105.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

413kB

Abstract

The efficacy of medicines, medical devices, and other health technologies should be proved in trials that assess final patient-relevant outcomes such as survival or morbidity. Market access and coverage decisions are, however, often based on surrogate end points, biomarkers, or intermediate end points, which aim to substitute and predict patient-relevant outcomes that are unavailable because of methodological, financial, or practical constraints. We provide a summary of the present use of surrogate end points in health care policy, discussing the case for and against their adoption and reviewing validation methods. We introduce a three-step framework for policymakers to handle surrogates, which involves establishing the level of evidence, assessing the strength of the association, and quantifying relations between surrogates and final outcomes. Although the use of surrogates can be problematic, they can, when selected and validated appropriately, offer important opportunities for more efficient clinical trials and faster access to new health technologies that benefit patients and health care systems.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Taylor, Professor Rod
Authors: Ciani, O., Buyse, M., Drummond, M., Rasi, G., Saad, E. D., and Taylor, R. S.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > MRC/CSO SPHSU
Journal Name:Value in Health
Publisher:Elsevier
ISSN:1098-3015
ISSN (Online):1524-4733
Published Online:22 December 2016
Copyright Holders:Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
First Published:First published in Value in Health 20(3):487-495
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record